Johnson & Johnson to begin testing its COVID vaccine on teens
The first tests will be on 16 ad 17 year olds.
Johnson & Johnson announced Friday that it will begin testing its COVID-19 vaccine on teenagers.
The pharmaceutical firm released a statement saying it would begin tests on teens 16 and 17 years old.
"The COVID-19 pandemic has had a profound impact on adolescents, not just with the complications of the disease, but with their education, mental health, and wellbeing," Dr. Paul Stoffels, M.D., the firm's chief scientific officer, said in the statement.
The study will be held in intervals of one, two, and three months after the shots to observe teens' response to the vaccine, according to the Associated Press.
The tests will be conducted in Spain and the United Kingdom.
News, Not Noise
- Prominent lawyer Sidney Powell defends self against a $2.5 billion Smartmatic defamation lawsuit
- Detroit absentee ballot instructions conflict with witness testimony about irregularities
- Zuckerberg group gave Detroit $7.4 million to 'dramatically' expand vote in city key to Biden win
- Nevada GOP censures Republican state official over allegations of 2020 voter fraud
- All eyes on Taiwan as U.S.-China tensions, rhetoric heat up